slow responders to glp 1 Beware! Don't Quit, Watch This! | EP. 03 Decoding the hallmarks of GLP-1RA
Description
Plaintiffs allege that the manufacturers of these drugs, Novo Nordisk and Eli Lily, failed to adequately warn users of these risks
This is particularly relevant given the intersection of estrogen signaling, GLP-1 pathways, and genetic risk factors related to APOE4 status
Both are about to change
GLP-1s appear to run that cycle in reverse
For postmenopausal women, they can be an effective tool during a stage of life when weight management often becomes more challenging
In intestinal inflammatory diseases and gastrointestinal tumors, microbiota, especially H
